Cite Filings / CNSP / 0001683168-26-006660
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEF 14A

Proxy Statement

CNS Pharmaceuticals, Inc. · Filed 2026-08-21 · Acc 0001683168-26-006660

Documents 1

  • DEF 14A Proxy Statement , cns_idef14a.htm

Around this filing

  • 2026-08-25 DEFA14A Proxy Materials
  • 2026-08-21 DEF 14A Proxy Statement
  • 2026-08-18 4 Director bought 2,000 shares at $5.00 ($10,000)
  • 2026-08-18 4 CEO and President acquired 4,750 shares (option exercise)
  • 2026-08-18 3 Initial Statement of Ownership
  • 2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-10-24 DEF 14A Proxy Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading cns_idef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…